and welcome to Arcturus Therapeutics quarterly financial update and pipeline progress call. Today's call will be led by Joe Payne, our President and CEO; and Andy Sassine, our CFO. Dr. Pad ...

"Arcturus continues to make excellent progress ... Ph.D., as Chair Designate. Dr. Slaoui is currently on the Company’s Board of Directors, a position he has held since June 2024.

Dr. Slaoui is currently on the Company’s Board of Directors, a position he has held since June 2024. Arcturus’ primary revenue streams include license fees, consulting and related technology ...